Anti-PD-1 antitumor immunity is enhanced by local and abrogated by systemic chemotherapy in GBM. (Record no. 26721269)
[ view plain ]
000 -LEADER | |
---|---|
fixed length control field | 02148 a2200649 4500 |
005 - DATE AND TIME OF LATEST TRANSACTION | |
control field | 20250517131756.0 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
fixed length control field | 201712s 0 0 eng d |
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
International Standard Serial Number | 1946-6242 |
024 7# - OTHER STANDARD IDENTIFIER | |
Standard number or code | 10.1126/scitranslmed.aag2942 |
Source of number or code | doi |
040 ## - CATALOGING SOURCE | |
Original cataloging agency | NLM |
Language of cataloging | eng |
Transcribing agency | NLM |
100 1# - MAIN ENTRY--PERSONAL NAME | |
Personal name | Mathios, Dimitrios |
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
Date of production, publication, distribution, manufacture, or copyright notice | 20171229 |
245 00 - TITLE STATEMENT | |
Title | Anti-PD-1 antitumor immunity is enhanced by local and abrogated by systemic chemotherapy in GBM. |
Medium | [electronic resource] |
260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
Name of publisher, distributor, etc. | Science translational medicine |
Date of publication, distribution, etc. | 12 2016 |
300 ## - PHYSICAL DESCRIPTION | |
Extent | 370ra180 p. |
Other physical details | digital |
500 ## - GENERAL NOTE | |
General note | Publication Type: Journal Article; Research Support, Non-U.S. Gov't |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Animals |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Antibodies, Monoclonal |
General subdivision | pharmacology |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Antibodies, Neoplasm |
General subdivision | pharmacology |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Antineoplastic Agents |
General subdivision | pharmacology |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Brain Neoplasms |
General subdivision | drug therapy |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Carmustine |
General subdivision | pharmacology |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Cell Line, Tumor |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Disease Models, Animal |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Disease Progression |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Female |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Flow Cytometry |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Glioblastoma |
General subdivision | drug therapy |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Glioma |
General subdivision | drug therapy |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Humans |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Immunosuppressive Agents |
General subdivision | pharmacology |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Immunotherapy |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Mice |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Mice, Inbred C57BL |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Microglia |
General subdivision | metabolism |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Programmed Cell Death 1 Receptor |
General subdivision | immunology |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Treatment Outcome |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Kim, Jennifer E |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Mangraviti, Antonella |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Phallen, Jillian |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Park, Chul-Kee |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Jackson, Christopher M |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Garzon-Muvdi, Tomas |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Kim, Eileen |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Theodros, Debebe |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Polanczyk, Magdalena |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Martin, Allison M |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Suk, Ian |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Ye, Xiaobu |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Tyler, Betty |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Bettegowda, Chetan |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Brem, Henry |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Pardoll, Drew M |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Lim, Michael |
773 0# - HOST ITEM ENTRY | |
Title | Science translational medicine |
Related parts | vol. 8 |
-- | no. 370 |
-- | p. 370ra180 |
856 40 - ELECTRONIC LOCATION AND ACCESS | |
Uniform Resource Identifier | <a href="https://doi.org/10.1126/scitranslmed.aag2942">https://doi.org/10.1126/scitranslmed.aag2942</a> |
Public note | Available from publisher's website |
No items available.